Our business strategy is focused on developing and commercializing important medicines for rare diseases and underserved patient populations. We explore a broad range of therapeutic areas that have technically challenging drug delivery mechanisms or other niche applications. Our goal is to create a broad portfolio of pharmaceutical products that will provide high-quality, affordable and accessible alternatives for patients that need them the most.
